Abrdn Life Sciences Investors Fund (HQL)
Abrdn Life Sciences Investors Fund
(HQL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2017 | 09-2011 | 09-2007 | 09-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | N/A | N/A | 50,510 | -21,440 |
| Other Working Capital | N/A | N/A | -32,080 | 33,830 |
| Other Operating Activity | 0 | 0 | -7,800 | -72,680 |
| Operating Cash Flow | $N/A | $N/A | $10,630 | $-60,290 |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $N/A | $0 | $0 |
| Cash Flows From Financing Activities | ||||
| Dividend Paid | N/A | N/A | -10,630 | -11,130 |
| Other Financing Activity | 0 | 0 | 0 | 71,400 |
| Financing Cash Flow | $N/A | $N/A | $-10,630 | $60,270 |
| Beginning Cash Position | N/A | N/A | 2 | 20 |
| End Cash Position | N/A | N/A | 1 | 1 |
| Net Cash Flow | $N/A | $N/A | $-1 | $-20 |
| Free Cash Flow | ||||
| Operating Cash Flow | N/A | N/A | 10,630 | -60,290 |
| Free Cash Flow | 0 | 0 | 10,630 | -60,290 |